LEI 391200C2AJUN6GEYNK86
Lipotype GmbH
Contract awards & public grants
Unlocking data content of Organ-On-Chips → LIPOTYPE
European Commission · DE · Grant · 2024-06-28
€397,350
Decision support for prediction and management of Long Covid Syndrome (LCS) → LIPOTYPE
European Commission · DE · Grant · 2022-05-23
€480,000
Stratification of Obesity Phenotypes to Optimize Future Therapy → LIPOTYPE
European Commission · DE · Grant · 2020-05-26
€300,000
Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe → LIPOTYPE
European Commission · DE · Grant · 2019-12-12
€758,750
Impact of exposome on the course of lung diseases → LIPOTYPE
European Commission · DE · Grant · 2019-12-06
€730,698
Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 → LIPOTYPE
European Commission · DE · Grant · 2016-12-20
€300,000
Genetic and Small Molecule Modifiers of Lysosomal Function → LIPOTYPE
European Commission · DE · Grant · 2016-10-28
€4,500
Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 → LIPOTYPE
European Commission · DE · Grant · 2016-06-07
€418,969
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.